Global Orogastric Tube Market Size By Type (Flexible Tube, Rigid Tube), By Application (Children Use, Adult Use), By Region, And Segment Forecasts, 2023 to 2032

The Global Orogastric Tube Market was valued at USD 0.78 billion in 2023 and is projected to reach USD 1.34 billion by 2031, expanding at a CAGR of 7.0% during the forecast period (2023–2031). Orogastric tubes are widely used in neonatal, pediatric, and adult care settings for gastric decompression, medication administration, and enteral feeding. Increasing incidences of gastrointestinal disorders, the rising prevalence of premature births requiring neonatal intensive care, and expanding applications in critical care settings are driving market demand. Furthermore, the integration of radiopaque materials and innovative safety features in orogastric tubes enhances their clinical efficacy and supports adoption across various healthcare facilities.

Drivers

Rising Neonatal Intensive Care Admissions

Premature births and neonatal complications are significantly increasing globally. Orogastric tubes are essential for providing nutrition and decompression in preterm infants who cannot feed orally. The growing demand for neonatal intensive care units (NICUs) is directly boosting the adoption of orogastric tubes.

Surge in Gastrointestinal and Critical Care Cases

The prevalence of gastrointestinal issues, such as ileus, bowel obstruction, and gastroparesis, is rising, particularly among the elderly population. Orogastric tubes are commonly used for gastric decompression in such conditions. Additionally, critical care patients requiring mechanical ventilation or sedation often depend on orogastric access.

Technological Advancements and Safety Features

Innovations such as tubes with integrated sensors, anti-reflux valves, and improved radiopacity for accurate placement are enhancing safety and efficacy, encouraging more healthcare providers to adopt advanced orogastric tubing systems.

Restraints

Risk of Misplacement and Associated Complications

Improper insertion of orogastric tubes can lead to severe complications like aspiration pneumonia, esophageal perforation, or airway misplacement. Despite advancements in technology, placement errors remain a concern, limiting market penetration in some settings.

Stringent Regulatory Approvals

Medical device regulations across regions such as the U.S. (FDA) and EU (CE marking) require extensive testing and validation. The time-consuming and costly regulatory processes can delay product launches and market expansion.

Opportunity

Growing Healthcare Infrastructure in Emerging Economies

The expansion of hospitals and NICUs in developing countries, coupled with increased government healthcare expenditure, presents a substantial opportunity for orogastric tube manufacturers. Enhanced training and awareness programs also aid in boosting adoption rates.

Integration with Smart Monitoring Systems

Emerging opportunities include integrating orogastric tubes with digital monitoring systems that alert caregivers to placement errors or reflux incidents. Such smart tubes represent a significant technological leap, offering safer alternatives in intensive care settings.

Market by System Type Insights

In 2023, the Silicone-based Orogastric Tube segment held the largest market share, owing to its superior biocompatibility, flexibility, and reduced risk of mucosal damage. Silicone tubes are especially preferred in neonatal and long-term care applications. Meanwhile, polyurethane tubes are witnessing growing demand due to their balance of rigidity and comfort, making them ideal for short- to medium-term use.

Market by End-use Insights

Hospitals were the leading end-users in 2023, accounting for over 60% of the market share. The high volume of surgical, emergency, and neonatal procedures in hospital settings fuels the need for orogastric tubes. The ambulatory surgical centers (ASCs) segment is anticipated to register significant growth over the forecast period due to the rising number of outpatient gastrointestinal and bariatric procedures requiring temporary decompression or enteral feeding.

Market by Regional Insights

North America dominated the global orogastric tube market in 2023, supported by a strong healthcare infrastructure, high neonatal care standards, and robust adoption of advanced medical devices. The Asia-Pacific region is expected to witness the fastest growth through 2031, driven by increasing birth rates, improving hospital infrastructure, and growing awareness in countries such as India and China.

Competitive Scenario

Key players in the Global Orogastric Tube Market include:

Cardinal Health Inc.

Becton, Dickinson and Company (BD)

Medtronic plc

Smiths Medical (ICU Medical)

B. Braun Melsungen AG

Vygon SA

Andersen Products Inc.

Teleflex Incorporated

Avanos Medical Inc.

Applied Medical Technology, Inc.

These companies are focusing on product innovation, regulatory approvals, and regional expansion to strengthen their market presence. Notable developments include:

In 2023, Becton Dickinson launched a next-gen neonatal orogastric tube featuring an integrated anti-reflux valve.

In 2024, Medtronic partnered with a European children's hospital network to deploy sensor-enabled feeding tubes in NICUs.

In 2025, Teleflex expanded its production capacity in Asia to meet the growing regional demand for critical care products.

Scope of Work – Global Orogastric Tube Market

Report Metric Details

Market Size (2023) USD 0.78 billion

Projected Market Size (2031) USD 1.34 billion

CAGR (2023–2031) 7.0%

Market Segments By System Type (Silicone, Polyurethane), End-use (Hospitals, ASCs)

Growth Drivers Increasing NICU admissions, gastrointestinal disease burden, product innovations

Opportunities Emerging markets, smart tube integration

Key Market Developments

2023: B. Braun introduced a radiopaque neonatal orogastric tube line in Europe, enhancing safety during critical interventions.

2024: Smiths Medical unveiled a polyurethane orogastric tube with embedded sensors for pediatric intensive care units.

2025: Avanos Medical collaborated with AI startups to test real-time placement monitoring systems in adult critical care.

FAQs

1) What is the current market size of the Global Orogastric Tube Market?

The market was valued at USD 0.78 billion in 2023.

2) What is the major growth driver of the Global Orogastric Tube Market?

The major growth driver is the increasing incidence of gastrointestinal disorders and the rising number of neonatal intensive care admissions.

3) Which is the largest region during the forecast period in the Global Orogastric Tube Market?

North America holds the largest market share due to advanced healthcare infrastructure and high NICU demand.

4) Which segment accounted for the largest market share in the Global Orogastric Tube Market?

The Silicone-based Orogastric Tube segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Orogastric Tube Market?

Major players include Cardinal Health, Medtronic, BD, Smiths Medical, B. Braun, and Teleflex.